◆ TICKERBASE · US STOCK FINANCIAL DATA LIBRARY

HomeAll stocks › WGS

GeneDx Holdings Corp. (WGS) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Diagnostics & Research · DATA UPDATED 2026-07-10

GeneDx Holdings Corp. (WGS) operates in the Diagnostics & Research industry and is headquartered in Stamford, United States with about 1,300 employees. Its market capitalization is roughly $2 billion. In the fiscal year ended 2025-12-31, WGS reported $428M in revenue and ($21M) in net income.

GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services.

Interactive charts & full statements → Open the WGS valuation workbench →

WGS Revenue & Earnings History — Annual Income Statement

Income statement2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Revenue$428M$305M$203M$235M
Gross Profit$298M$194M$90M($27M)
Operating Income (EBIT)($13M)($23M)($170M)($458M)
Net Income($21M)($52M)($176M)($549M)

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

WGS Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
Total Revenue$102M$121M$117M$103M$87M
Gross Profit$68M$84M$84M$71M$58M
Operating Income (EBIT)($26M)($14M)($3M)$9M($5M)
Net Income($63M)($18M)($8M)$11M($6M)

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

WGS Free Cash Flow History

WGS Balance Sheet History

Balance sheet2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Assets$524M$419M$419M$491M
Total Liabilities$216M$174M$191M$237M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive WGS viewer.

Other Companies in Diagnostics & Research

← WGRXAll stocksWH →

About TickerBase · Data methodology & sources

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.